IRIDEX CORP Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
IRIDEX CORP (IRIX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $0.69 per share for the 6-month period ending 2026-07-04, per its 10-Q filed 2026-08-18.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-08-18
- IRIDEX CORP share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2026-04-04 was $0.70, a 0.00% change year-over-year.
- IRIDEX CORP share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2025-03-29 was $0.70, a 60.00% decline year-over-year.
- IRIDEX CORP share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2024-03-30 was $1.75, a 25.90% increase year-over-year.
- IRIDEX CORP share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2023-04-01 was $1.39, a 51.23% decline year-over-year.
- IRIDEX CORP share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2026 was $0.57, a 61.22% decline from fiscal 2024.
- IRIDEX CORP share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $1.47, a 11.36% increase from fiscal 2023.
- IRIDEX CORP share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $1.32, a 14.84% decline from fiscal 2022.
- IRIDEX CORP share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $1.55, a 59.32% decline from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2026-07-04 | $0.69 10-Q · filed 2026-08-18 | |||
| 2026-04-04 | $0.70 10-Q · filed 2026-05-19 | |||
| 2026-01-03 | $0.57 10-K · filed 2026-04-02 | |||
| 2025-09-27 | $0.51 10-Q · filed 2025-11-12 | |||
| 2025-06-28 | $0.50 10-Q · filed 2026-08-18 | |||
| 2025-03-29 | $0.70 10-Q · filed 2026-05-19 | |||
| 2024-12-28 | $1.47 10-K · filed 2026-04-02 | |||
| 2024-09-28 | $1.66 10-Q · filed 2025-11-12 | |||
| 2024-06-29 | $1.82 10-Q · filed 2025-08-12 | |||
| 2024-03-30 | $1.75 10-Q · filed 2025-05-13 | |||
| 2023-12-30 | $1.32 10-K · filed 2025-03-27 | |||
| 2023-09-30 | $1.32 10-Q · filed 2024-11-12 | |||
| 2023-07-01 | $1.35 10-Q · filed 2024-08-08 | |||
| 2023-04-01 | $1.39 10-Q · filed 2024-05-14 | |||
| 2022-12-31 | $1.55 10-K · filed 2024-03-29 | |||
| 2022-10-01 | $2.18 10-Q · filed 2023-11-20 | |||
| 2022-07-02 | $2.68 10-Q · filed 2022-08-15 | |||
| 2022-04-02 | $2.85 10-Q · filed 2023-05-11 | |||
| 2022-01-01 | $3.81 10-K · filed 2023-03-09 | |||
| 2021-10-02 | $3.79 10-Q · filed 2022-11-10 | |||
| 2021-07-03 | $3.86 10-Q · filed 2022-08-15 | |||
| 2021-04-03 | $2.74 10-Q · filed 2022-05-12 | |||
| 2021-01-02 | $1.06 10-K · filed 2022-03-15 | |||
| 2020-09-26 | $1.06 10-Q · filed 2021-11-12 | |||
| 2020-06-27 | $1.01 10-Q · filed 2021-08-12 | |||
| 2020-03-28 | $1.05 10-Q · filed 2021-05-12 | |||
| 2019-12-28 | $1.65 10-K · filed 2021-03-23 | |||
| 2019-09-28 | $1.47 10-Q · filed 2019-11-08 | $1.75 10-Q · filed 2020-11-10 | ||
| 2019-06-29 | $1.76 10-Q · filed 2019-08-07 | $1.93 10-Q · filed 2020-08-07 | ||
| 2019-03-30 | $1.70 10-Q · filed 2020-05-12 | |||
| 2018-12-29 | $2.27 10-K · filed 2020-03-13 | |||
| 2018-09-29 | $2.47 10-Q · filed 2019-11-08 | $2.34 10-Q · filed 2019-11-08 | ||
| 2018-06-30 | $2.32 10-Q · filed 2019-08-07 | $2.28 10-Q · filed 2018-08-08 | ||
| 2018-03-31 | $2.21 10-Q · filed 2019-05-07 | |||
| 2017-12-30 | $3.68 10-K · filed 2019-03-29 | |||
| 2017-09-30 | $3.55 10-Q · filed 2018-11-06 | $3.75 10-Q · filed 2018-11-06 | ||
| 2017-07-01 | $4.22 10-Q · filed 2018-08-08 | $4.92 10-Q · filed 2018-08-08 | ||
| 2017-04-01 | $5.44 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | $5.06 10-K · filed 2018-03-14 | |||
| 2016-10-01 | $6.37 10-Q · filed 2017-11-07 | $5.23 10-Q · filed 2017-11-07 | ||
| 2016-07-02 | $4.33 10-Q · filed 2017-08-08 | $4.21 10-Q · filed 2017-08-08 | ||
| 2016-04-02 | $4.14 10-Q · filed 2017-05-09 | |||
| 2016-01-02 | $3.95 10-K · filed 2018-03-14 | |||
| 2015-10-03 | $2.77 10-Q · filed 2016-11-07 | $4.23 10-Q · filed 2016-11-07 | ||
| 2015-07-04 | $4.40 10-Q · filed 2016-08-08 | $4.57 10-Q · filed 2016-08-08 | ||
| 2015-04-04 | $4.61 10-Q · filed 2016-05-09 | |||
| 2015-01-03 | $4.02 10-K · filed 2017-03-15 | |||
| 2014-09-27 | $3.54 10-Q · filed 2015-11-10 | $4.06 10-Q · filed 2015-11-10 | ||
| 2014-06-28 | $4.09 10-Q · filed 2015-08-10 | $4.09 10-Q · filed 2015-08-10 | ||
| 2014-03-29 | $4.09 10-Q · filed 2015-05-12 | |||
| 2013-12-28 | $3.16 10-K · filed 2016-03-31 | |||
| 2013-09-28 | $3.19 10-Q · filed 2014-11-03 | $3.12 10-Q · filed 2014-11-03 | ||
| 2013-06-29 | $2.89 10-Q · filed 2014-08-04 | $3.00 10-Q · filed 2014-08-04 | ||
| 2013-03-30 | $3.05 10-Q · filed 2014-05-05 | |||
| 2012-12-29 | $2.60 10-K · filed 2015-04-02 | |||
| 2012-09-29 | $2.37 10-Q · filed 2013-11-04 | $2.70 10-Q · filed 2013-11-04 | ||
| 2012-06-30 | $2.75 10-Q · filed 2013-08-05 | $2.77 10-Q · filed 2013-08-05 | ||
| 2012-03-31 | $2.88 10-Q · filed 2013-05-06 | |||
| 2011-12-31 | $2.47 10-K · filed 2014-03-27 | |||
| 2011-01-01 | $2.70 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |